Cargando…

C-fos upregulates P-glycoprotein, contributing to the development of multidrug resistance in HEp-2 laryngeal cancer cells with VCR-induced resistance

BACKGROUND: Laryngeal cancer tends to have a very poor prognosis due to the unsatisfactory efficacy of chemotherapy for this cancer. Multidrug resistance (MDR) is the main cause of chemotherapy failure. The proto-oncogene c-fos has been shown to be involved in the development of MDR in several tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Guodong, Hu, Xiaoling, Sun, Lu, Li, Xin, Li, Jianfeng, Li, Tongli, Zhang, Xiaohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819209/
https://www.ncbi.nlm.nih.gov/pubmed/29483928
http://dx.doi.org/10.1186/s11658-017-0067-8
_version_ 1783301166249017344
author Li, Guodong
Hu, Xiaoling
Sun, Lu
Li, Xin
Li, Jianfeng
Li, Tongli
Zhang, Xiaohui
author_facet Li, Guodong
Hu, Xiaoling
Sun, Lu
Li, Xin
Li, Jianfeng
Li, Tongli
Zhang, Xiaohui
author_sort Li, Guodong
collection PubMed
description BACKGROUND: Laryngeal cancer tends to have a very poor prognosis due to the unsatisfactory efficacy of chemotherapy for this cancer. Multidrug resistance (MDR) is the main cause of chemotherapy failure. The proto-oncogene c-fos has been shown to be involved in the development of MDR in several tumor types, but few studies have evaluated the relationship between c-fos and MDR in laryngeal cancer. We investigated the role of c-fos in MDR development in laryngeal cancer cells (cell line: human epithelial type 2, HEp-2) using the chemotherapeutic vincristine (VCR). METHODS: HEp-2/VCR drug resistance was established by selection against an increasing drug concentration gradient. The expressions of c-fos and multidrug resistance 1 (mdr1) were measured using qPCR and western blot. C-fos overexpression or knockdown was performed in various cells. The intracellular rhodamine-123 (Rh-123) accumulation assay was used to detect the transport capacity of P-glycoprotein (P-gp, which is encoded by the mdr1 gene). RESULTS: HEp-2 cells with VCR-induced resistance (HEp-2/VCR cells) were not only resistant to VCR but also evolved cross-resistance to other chemotherapeutic drugs. The expressions of the c-fos and mdr1genes were significantly higher in the HEp-2/VCR cells than in control cells. C-fos overexpression in HEp-2 cells (c-fos WT) resulted in increased P-gp expression and increased the IC(50) for 5-FU. C-fos knockdown in the HEp-2/VCR cells (c-fos shRNA) resulted in decreased P-gp expression and decreased IC(50) for 5-FU. An intracellular Rh-123 accumulation assay showed that the mean intracellular fluorescence intensity (MFI) was lower in the HEp-2/VCR cells than in HEp-2 cells. C-fos WT cells also showed lower MFI. By contrast, c-fos shRNA cells exhibited a higher MFI than the control group. CONCLUSION: C-fos increased the expression of P-gp and mdr1 in the HEp-2/VCR cells, and enhanced the efflux function of the cells, thereby contributing to the development of MDR.
format Online
Article
Text
id pubmed-5819209
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58192092018-02-26 C-fos upregulates P-glycoprotein, contributing to the development of multidrug resistance in HEp-2 laryngeal cancer cells with VCR-induced resistance Li, Guodong Hu, Xiaoling Sun, Lu Li, Xin Li, Jianfeng Li, Tongli Zhang, Xiaohui Cell Mol Biol Lett Research BACKGROUND: Laryngeal cancer tends to have a very poor prognosis due to the unsatisfactory efficacy of chemotherapy for this cancer. Multidrug resistance (MDR) is the main cause of chemotherapy failure. The proto-oncogene c-fos has been shown to be involved in the development of MDR in several tumor types, but few studies have evaluated the relationship between c-fos and MDR in laryngeal cancer. We investigated the role of c-fos in MDR development in laryngeal cancer cells (cell line: human epithelial type 2, HEp-2) using the chemotherapeutic vincristine (VCR). METHODS: HEp-2/VCR drug resistance was established by selection against an increasing drug concentration gradient. The expressions of c-fos and multidrug resistance 1 (mdr1) were measured using qPCR and western blot. C-fos overexpression or knockdown was performed in various cells. The intracellular rhodamine-123 (Rh-123) accumulation assay was used to detect the transport capacity of P-glycoprotein (P-gp, which is encoded by the mdr1 gene). RESULTS: HEp-2 cells with VCR-induced resistance (HEp-2/VCR cells) were not only resistant to VCR but also evolved cross-resistance to other chemotherapeutic drugs. The expressions of the c-fos and mdr1genes were significantly higher in the HEp-2/VCR cells than in control cells. C-fos overexpression in HEp-2 cells (c-fos WT) resulted in increased P-gp expression and increased the IC(50) for 5-FU. C-fos knockdown in the HEp-2/VCR cells (c-fos shRNA) resulted in decreased P-gp expression and decreased IC(50) for 5-FU. An intracellular Rh-123 accumulation assay showed that the mean intracellular fluorescence intensity (MFI) was lower in the HEp-2/VCR cells than in HEp-2 cells. C-fos WT cells also showed lower MFI. By contrast, c-fos shRNA cells exhibited a higher MFI than the control group. CONCLUSION: C-fos increased the expression of P-gp and mdr1 in the HEp-2/VCR cells, and enhanced the efflux function of the cells, thereby contributing to the development of MDR. BioMed Central 2018-02-20 /pmc/articles/PMC5819209/ /pubmed/29483928 http://dx.doi.org/10.1186/s11658-017-0067-8 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Li, Guodong
Hu, Xiaoling
Sun, Lu
Li, Xin
Li, Jianfeng
Li, Tongli
Zhang, Xiaohui
C-fos upregulates P-glycoprotein, contributing to the development of multidrug resistance in HEp-2 laryngeal cancer cells with VCR-induced resistance
title C-fos upregulates P-glycoprotein, contributing to the development of multidrug resistance in HEp-2 laryngeal cancer cells with VCR-induced resistance
title_full C-fos upregulates P-glycoprotein, contributing to the development of multidrug resistance in HEp-2 laryngeal cancer cells with VCR-induced resistance
title_fullStr C-fos upregulates P-glycoprotein, contributing to the development of multidrug resistance in HEp-2 laryngeal cancer cells with VCR-induced resistance
title_full_unstemmed C-fos upregulates P-glycoprotein, contributing to the development of multidrug resistance in HEp-2 laryngeal cancer cells with VCR-induced resistance
title_short C-fos upregulates P-glycoprotein, contributing to the development of multidrug resistance in HEp-2 laryngeal cancer cells with VCR-induced resistance
title_sort c-fos upregulates p-glycoprotein, contributing to the development of multidrug resistance in hep-2 laryngeal cancer cells with vcr-induced resistance
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819209/
https://www.ncbi.nlm.nih.gov/pubmed/29483928
http://dx.doi.org/10.1186/s11658-017-0067-8
work_keys_str_mv AT liguodong cfosupregulatespglycoproteincontributingtothedevelopmentofmultidrugresistanceinhep2laryngealcancercellswithvcrinducedresistance
AT huxiaoling cfosupregulatespglycoproteincontributingtothedevelopmentofmultidrugresistanceinhep2laryngealcancercellswithvcrinducedresistance
AT sunlu cfosupregulatespglycoproteincontributingtothedevelopmentofmultidrugresistanceinhep2laryngealcancercellswithvcrinducedresistance
AT lixin cfosupregulatespglycoproteincontributingtothedevelopmentofmultidrugresistanceinhep2laryngealcancercellswithvcrinducedresistance
AT lijianfeng cfosupregulatespglycoproteincontributingtothedevelopmentofmultidrugresistanceinhep2laryngealcancercellswithvcrinducedresistance
AT litongli cfosupregulatespglycoproteincontributingtothedevelopmentofmultidrugresistanceinhep2laryngealcancercellswithvcrinducedresistance
AT zhangxiaohui cfosupregulatespglycoproteincontributingtothedevelopmentofmultidrugresistanceinhep2laryngealcancercellswithvcrinducedresistance